# FDA Inspection 1077032 - Vitalant - January 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/vitalant/153eb07e-059c-48ca-91e5-94e8b8f29248
Source feed: FDA_Inspections

> FDA Inspection 1077032 for Vitalant on January 22, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1077032
- Company Name: Vitalant
- Inspection Date: 2019-01-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1168932 - 2022-05-04](https://www.keypedia.com/records/fda_inspections/vitalant/5049772e-ab19-49c3-b3b7-d2457e194d78)
- [FDA Inspection 1168932 - 2022-05-04](https://www.keypedia.com/records/fda_inspections/vitalant/6fbd0340-7c85-47ae-a031-4fbcb47f12f4)
- [FDA Inspection 994412 - 2016-12-14](https://www.keypedia.com/records/fda_inspections/vitalant/11046614-170e-482e-b691-39cde3f725d6)
- [FDA Inspection 899256 - 2014-10-08](https://www.keypedia.com/records/fda_inspections/vitalant/1f3ad6dc-3cdd-4a6f-930b-8ba26c187b60)
- [FDA Inspection 804109 - 2012-10-23](https://www.keypedia.com/records/fda_inspections/vitalant/91aa5ea6-9749-4d06-b14a-cd11a70d3560)

Company: https://www.keypedia.com/companies/vitalant/3f82d2c7-e51d-4a6e-8062-d4ba06b77c19

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d